Abstract
The in vitro activities of N-formimidoyl thienamycin, clindamycin, chloramphenicol, metronidazole, cefoperazone, cefotaxime, cefoxitin, moxalactam, penicillin G, and piperacillin were determined against 158 anaerobic bacteria isolated from endometrial wash cultures of women with pelvic infections. In general, N-formimidoyl thienamycin was the most active, with all organisms inhibited by less than or equal to 0.5 microgram/ml. Chloramphenicol, clindamycin, and metronidazole inhibited all organisms by less than or equal to 8 microgram/ml. The penicillins and cephalosporins exhibited variable activity of lesser degrees.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cherubin C. E., Corrado M. L., Sierra M. F., Gombert M. E., Shulman M. Susceptibility of gram-positive cocci to various antibiotics, including cefotaxime, moxalactam, and N-formimidoyl thienamycin. Antimicrob Agents Chemother. 1981 Oct;20(4):553–555. doi: 10.1128/aac.20.4.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cunningham F. G., Hemsell D. L., DePalma R. T., Kappus S., Roark M., Nobles B. Moxalactam for obstetric and gynecologic infections. In vitro and dose-finding studies. Am J Obstet Gynecol. 1981 Apr 15;139(8):915–921. doi: 10.1016/0002-9378(81)90958-3. [DOI] [PubMed] [Google Scholar]
- Gall S. A., Kohan A. P., Ayers O. M., Hughes C. E., Addison W. A., Hill G. B. Intravenous metronidazole or clindamycin with tobramycin for therapy of pelvic infections. Obstet Gynecol. 1981 Jan;57(1):51–58. [PubMed] [Google Scholar]
- Gibbs R. S., Blanco J. D., Castaneda Y. S., St Clair P. J. Therapy of obstetrical infections with moxalactam. Antimicrob Agents Chemother. 1980 Jun;17(6):1004–1007. doi: 10.1128/aac.17.6.1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jorgensen J. H., Crawford S. A., Alexander G. A. Comparison of moxalactam (LY127935) and cefotaxime against anaerobic bacteria. Antimicrob Agents Chemother. 1980 May;17(5):901–904. doi: 10.1128/aac.17.5.901. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nasu M., Maskell J. P., Williams R. J., Williams J. D. In vitro activity of MK0787 (N-formimidoyl thienamycin) and other beta-lactam compounds against Bacteroides spp. Antimicrob Agents Chemother. 1981 Oct;20(4):433–436. doi: 10.1128/aac.20.4.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rolfe R. D., Finegold S. M. Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria. Antimicrob Agents Chemother. 1981 Nov;20(5):600–609. doi: 10.1128/aac.20.5.600. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sweet R. L., Ledger W. J. Cefoxitin: single-agent treatment of mixed aerobic-anaerobic pelvic infections. Obstet Gynecol. 1979 Aug;54(2):193–198. [PubMed] [Google Scholar]
- Tally F. P., Jacobus N. V., Gorbach S. L. In vitro activity of N-formimidoyl thienamycin (MK0787). Antimicrob Agents Chemother. 1980 Oct;18(4):642–644. doi: 10.1128/aac.18.4.642. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tutlane V. A., McCloskey R. V., Trent J. A. In vitro comparison of N-formimidoyl thienamycin, piperacillin, cefotaxime, and cefoperazone. Antimicrob Agents Chemother. 1981 Jul;20(1):140–143. doi: 10.1128/aac.20.1.140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Verbist L., Verhaegen J. In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime. Antimicrob Agents Chemother. 1981 Mar;19(3):402–406. doi: 10.1128/aac.19.3.402. [DOI] [PMC free article] [PubMed] [Google Scholar]